Guangdong Jiaying Pharmaceutical (002198) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

002198 Guangdong Jiaying Pharmaceutical

Watchlist

6.98
-0.19-2.65%

Not Open Jan 15 15:00 CST

3.54BMarket Cap290.83P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Jiaying Pharmaceutical to Buy Back Up to 132 Million Yuan of Shares
MT NewswiresDec 16, 2024 02:32 ET
There's Reason For Concern Over Guangdong Jiaying Pharmaceutical Co., Ltd's (SZSE:002198) Massive 26% Price Jump
Simply Wall StNov 15, 2024 17:31 ET
Guangdong Jiaying Pharmaceutical Co., Ltd's (SZSE:002198) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Simply Wall StOct 1, 2024 21:13 ET
Subdued Growth No Barrier To Guangdong Jiaying Pharmaceutical Co., Ltd's (SZSE:002198) Price
Simply Wall StJul 11, 2024 23:29 ET
Some May Be Optimistic About Guangdong Jiaying Pharmaceutical's (SZSE:002198) Earnings
Simply Wall StMay 4, 2024 21:43 ET
Guangdong Jiaying Pharmaceutical (SZSE:002198) Delivers Shareholders Favorable 9.6% CAGR Over 3 Years, Surging 16% in the Last Week Alone
Simply Wall StMar 12, 2024 18:42 ET

Comments

Moomoo AI

Mar 12, 2024 18:09

The last year's loss could be a temporary blip on the journey to a brighter future for Guangdong Jiaying Pharmaceutical. The company's profitability in the last three years would have been expected to drive a higher share price.

Guangdong Jiaying Pharmaceutical (SZSE:002198) Delivers Shareholders Favorable 9.6% CAGR Over 3 Years, Surging 16% in the Last Week Alone

Moomoo AI

Feb 2, 2024 18:17

Despite a high P/E ratio, the company's recent earnings trajectory is less appealing compared to the market. Investors overlook limited growth, hoping for a business turnaround. However, disappointment may loom if the P/E aligns with recent growth rates. The company's three-year earnings trends aren't impacting its high P/E as expected.

Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Moomoo AI

Jan 25, 2024 01:26

Guangdong Jiaying Pharmaceutical's impressive EPS growth and substantial insider ownership indicate promising growth potential and improved business economics.

Do Guangdong Jiaying Pharmaceutical's (SZSE:002198) Earnings Warrant Your Attention?

Moomoo AI

Nov 20, 2023 17:53

Guangdong Jiaying Pharmaceutical shows significant net income growth despite seeming unimpressive ROE, suggesting efficient management. Full reinvestment of profits further adds to the company's positive outlook despite lower-than-average industry ROE.